{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:26:09Z","timestamp":1794324369891,"version":"4.9.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008867","name":"Department of Education of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.153878","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:58:27Z","timestamp":1785700707000},"page":"153878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Mitochondrial ribosomal protein S30 inhibits ferroptosis and promotes tumor progression in hepatocellular carcinoma via suppressing GPX4 ubiquitination"],"prefix":"10.1016","volume":"381","author":[{"given":"Weihui","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.153878_bb0005","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","article-title":"Goals and targets for personalized therapy for HCC","volume":"13","author":"Couri","year":"2019","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0030","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(25)00403-9","article-title":"Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial","volume":"405","author":"Yau","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0035","article-title":"ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion","volume":"82","author":"T","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0040","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jhep.2024.12.016","article-title":"Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma","volume":"82","author":"Cappuyns","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0045","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0050","article-title":"Potential therapies for HCC involving targeting the ferroptosis pathway","volume":"14","author":"D","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301928","article-title":"PGAM1 inhibition promotes HCC ferroptosis and synergizes with anti-PD-1 immunotherapy","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0060","article-title":"Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis","volume":"122","author":"R","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0070","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","article-title":"Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103179","article-title":"Mitochondrial GPX4 acetylation is involved in cadmium-induced renal cell ferroptosis","volume":"73","author":"Guo","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0085","article-title":"Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated GPX4 ubiquitination","volume":"14","author":"X","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103270","article-title":"LACTB suppresses liver cancer progression through regulation of ferroptosis","volume":"75","author":"Zeng","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0095","doi-asserted-by":"crossref","first-page":"19363","DOI":"10.1074\/jbc.M100727200","article-title":"The small subunit of the mammalian mitochondrial ribosome. Identification of the full complement of ribosomal proteins present","volume":"276","author":"Cavdar Koc","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2013.11.008","article-title":"The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors","volume":"8","author":"Quigley","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01170","article-title":"MRPS30-DT knockdown inhibits breast cancer progression by targeting Jab1\/Cops5","volume":"9","author":"Wu","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0110","article-title":"The web-based portal SpatialTME integrates histological images with single-cell and spatial transcriptomics to explore the tumor microenvironment","volume":"84","author":"J","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0115","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41467-023-36560-7","article-title":"Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis","volume":"14","author":"Xun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0120","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s10529-012-1025-1","article-title":"Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers","volume":"34","author":"Pan","year":"2012","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0130","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.7150\/ijbs.77979","article-title":"Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation","volume":"19","author":"Zhou","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0135","article-title":"USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy","volume":"121","author":"Li","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0145","first-page":"36","article-title":"The impact of TP53-induced glycolysis and apoptosis regulator on prognosis in hepatocellular carcinoma: association with tumor microenvironment and ferroptosis","volume":"14","author":"Toshida","year":"2025","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0150","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Y","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0155","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.7150\/thno.48739","article-title":"Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma","volume":"11","author":"Song","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0160","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-21-4337","article-title":"Asialoglycoprotein receptor 1 functions as a tumor suppressor in liver cancer via inhibition of STAT3","volume":"82","author":"Zhu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0170","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0175","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41419-023-06222-z","article-title":"The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0180","article-title":"PUB25 and PUB26 dynamically modulate ICE1 stability via differential ubiquitination during cold stress in Arabidopsis","volume":"35","author":"X","year":"2023","journal-title":"Plant Cell"},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0185","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41467-020-14324-x","article-title":"Nedd4 ubiquitylates VDAC2\/3 to suppress erastin-induced ferroptosis in melanoma","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0195","article-title":"Ferroptosis in cancer therapy: mechanisms, small molecule inducers, and novel approaches","volume":"18","author":"Y","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2026.153878_bb0205","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1038\/s41388-025-03581-z","article-title":"Targeting JMJD6\/PPAR\u03b3\/GPX4 axis overcomes ferroptosis resistance and enhances therapeutic efficacy in hepatocellular carcinoma","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026038249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026038249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:26:21Z","timestamp":1794320781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026038249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S0141813026038249"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153878","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial ribosomal protein S30 inhibits ferroptosis and promotes tumor progression in hepatocellular carcinoma via suppressing GPX4 ubiquitination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153878"}}